![Katelyn O'Brien, PharmD, BCPS, CDCES, BC-ADM Profile](https://pbs.twimg.com/profile_images/1174093621072711680/YP-BFt2O_x96.jpg)
Katelyn O'Brien, PharmD, BCPS, CDCES, BC-ADM
@KOBPharmD
Followers
2K
Following
7K
Statuses
2K
Clinical Pharmacy Specialist #ambcarerx All things #diabetes and #CGM Opinions are my own. she/her/hers
Boston, MA
Joined September 2019
🧵A thread... on #T2DM and #Ramadan2022 When is Ramadan? 📅 This year, it begins the evening of Saturday, April 2nd and ends at sundown on Sunday, May 1st. 1/
8
30
120
RT @ADA_DiabetesPro: Learn how to integrate automated insulin delivery (AID) devices into your clinical practice in our upcoming workshop,…
0
1
0
RT @scottisaacsmd: Use of glucose-lowering medications in the management of type 2 diabetes. @ADA_DiabetesPro Standards of Care in Diabet…
0
52
0
RT @ConscienHealth: The #hype of #ContinuousGlucoseMonitoring to finetune your lifestyle explains a lot. Health becomes a luxury in commerc…
0
7
0
I’ll be at @ASHPOfficial Midyear Clinical Meeting #ASHP #ASHP24 Will be at PPS and the Showcase Monday. Recruiting for PGY2 in #AmbcareRx @The_BMC
0
0
4
RT @Drhkakturk: Insulet Announces Omnipod® 5 System is Now Compatible with Abbott’s FreeStyle Libre 2 Plus Sensor in the U.S. | Business Wi…
0
11
0
November is #DiabetesAwarenessMonth I’ll be at the #Boston event on 11/22-23. Two days, one dedicated for #HCP and one dedicated for community members and #PWD Looking forward to the event!
November is here, and with it comes the ADA's State of Diabetes events, no-cost events that bring together influential figures across various sectors to discuss the current landscape of diabetes. Find an event near you at #AmericanDiabetesMonth
0
0
2
If you’re interested in @The_BMC for your pharmacy residency training, check out our upcoming open houses happening virtually this month! We’ll also be at @ASHPOfficial #Midyear in December. #PharmRes #PGY1 #PGY2 #ambcarerx
0
0
1
This is important data! Oral semaglutide for CV risk reduction in T2DM. Looking forward to full publication to understand differences in SOUL trial and PIONEER
#PRESS: Oral product demonstrates a 14% reduction in risk of major adverse cardiovascular events in adults with type 2 diabetes in phase 3 trial
1
1
6
Presenting this afternoon @eatrightFNCE @eatright @eatrightPRO #obesity is a chronic disease and needs interdisciplinary collaboration
0
0
3
RT @LillyMedical: New Publication Alert! Explore the latest science in Type 2 #Diabetes from the QWINT-2 Phase 3 clinical trial, now avail…
0
3
0
RT @Drhkakturk: Insulin Titration Recommendations When Using Glucagon-Like Peptide 1 Receptor Agonist Therapy in Adults With Type 1 Diabete…
0
8
0
RT @Drhkakturk: In a first-of-its-kind fixed dose study, once weekly insulin efsitora alfa leads to A1C reduction similar to daily insulin…
0
5
0
RT @BetaBionics: We’re excited to announce that we’re partnering with @AbbottNews and @FreeStyleDiabet to integrate the FreeStyle Libre 3 P…
0
7
0
@richard_waithe @DianaMIsaacs For me, I noticed when setting up the app, the steps were text only. Would be nice to have audio option for visually impaired. G7 app has videos to watch on meaning of arrows etc. would be nice to add for Stelo.
1
0
5
If you are an MD, DO, NP, PA working in #primarycare and looking to earn #CEU #CME on #obesitymanagement , consider joinging this small group based learning I am leading.The Good Fight - Overcoming Challenges to Combat Obesity and Overweight 2024
0
0
1
Exciting to see #diabetestech as OTC #Stelo Still have room to grow for equitable access with out of pocket cost, insurance coverage, and those without internet access to purchase online
1
2
10
RT @myomnipod: We’re excited to share that the Omnipod® 5 Automated Insulin Delivery System is now indicated for adults with type 2 diabete…
0
7
0
RT @EliLillyandCo: Today, we shared results from a three-year study evaluating a potential treatment to reduce the risk of progression to t…
0
9
0